Press Release – New York, NY – April 8, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sunshine Biopharma Inc. (NASDAQ: SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, in its $2.46 million registered direct offering.
The SRFC team was led by partners Gregory Sichenzia, Jeff Cahlon and Marcelle Balcombe.
